• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

UTSA researcher receives $1.9 million HHS grant to develop anti-fungal vaccine

Bioengineer by Bioengineer
July 23, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

(SAN ANTONIO, July 23, 2018) — Chiung-Yu Hung, assistant professor of biology at The University of Texas at San Antonio (UTSA), has received a five-year, $1.9 million grant from the U.S. Department of Health and Human Services to support her efforts to create a vaccine for fungal infections.

Unlike bacteria or viruses, there is currently no vaccine available for any type of fungal infection. Fungi are more complex organisms, containing far more components, which makes developing an effective vaccine to battle them much more difficult than efforts to combat a virus or bacterial infection.

Hung's work focuses on two types of the fungus Coccidioides, which exists in the soil of Southwest Texas, Southern Arizona, California and Northern Mexico. When the soil is disturbed by animals or humans, the fungal spores are released into the air, causing a respiratory infection called valley fever.

"Any human living in the endemic area could inhale the spores into their lungs, which causes an infection," Hung said. "The majority of people don't feel it, but some of them will develop flu-like symptoms and a small portion could even develop chronic pneumonia."

Without proper treatment, the fungus could also spread to the central nervous system, where it could cause meningitis, a potentially fatal condition. Hung's goal is to stop these infections before they occur by developing what could be the first anti-fungal vaccine.

"It's a testament to the advances in vaccines for viruses and bacteria that this effort is now possible," Hung said. "It's very exciting to be breaking new ground and working to create something that could prevent illness and even save lives."

As a member of the university's South Texas Center for Emerging Infectious Diseases, Hung is one of many researchers specializing in the study of vaccine development, biodefense, immunology and molecular microbiology. She is the author of several studies on Coccidioides and similar fungi.

"I welcome the HHS funding for University of Texas at San Antonio's (UTSA) South Texas Center for Emerging Infectious Diseases, which focuses on fungal infections with the Coccidioides species," said Congressman Joaquin Castro. "San Antonio continues to lead in medicine development with groundbreaking research, and this grant will help boost wellness and quality of life for Americans across Texas and our nation."

###

Learn more about the South Texas Center for Emerging Infectious Diseases at UTSA.

Learn more about the UTSA Department of Biology.

Media Contact

Christi Fish
[email protected]
210-458-5141
@utsa

http://www.utsa.edu

https://www.utsa.edu/today/2018/07/story/HungGrant.html

Share12Tweet8Share2ShareShareShare2

Related Posts

Succinate Receptor 1 Limits Blood Cell Formation, Leukemia

February 7, 2026

Palmitoylation of Tfr1 Drives Platelet Ferroptosis and Exacerbates Liver Damage in Heat Stroke

February 7, 2026

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

February 7, 2026

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Succinate Receptor 1 Limits Blood Cell Formation, Leukemia

Palmitoylation of Tfr1 Drives Platelet Ferroptosis and Exacerbates Liver Damage in Heat Stroke

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.